{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:12:05Z","timestamp":1792548725232,"version":"4.5.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","funder":[{"DOI":"10.13039\/501100004817","name":"Lund University Medical Faculty Foundation","doi-asserted-by":"publisher","award":["YF 2020-YF0056"],"award-info":[{"award-number":["YF 2020-YF0056"]}],"id":[{"id":"10.13039\/501100004817","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Harmful glucose exposure and absorption remain major limitations of peritoneal dialysis (PD). We previously showed that inhibition of sodium glucose cotransporter 2 did not affect glucose transport during PD in rats. However, more recently, we found that phlorizin, a dual blocker of sodium glucose cotransporters 1 and 2, reduces glucose diffusion in PD. Therefore, either inhibiting sodium glucose cotransporter 1 or blocking facilitative glucose channels by phlorizin metabolite phloretin would reduce glucose transport in PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We tested a selective blocker of sodium glucose cotransporter 1, mizagliflozin, as well as phloretin, a nonselective blocker of facilitative glucose channels, in an anesthetized Sprague\u2013Dawley rat model of PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Intraperitoneal phloretin treatment reduced glucose absorption by &gt;30% and resulted in a &gt;50% higher ultrafiltration rate compared with control animals. Sodium removal and sodium clearances were similarly improved, whereas the amount of ultrafiltration per millimole of sodium removed did not differ. Mizagliflozin did not influence glucose transport or osmotic water transport.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Taken together, our results and previous results indicate that blockers of facilitative glucose channels may be a promising target for reducing glucose absorption and improving ultrafiltration efficiency in PD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.2022040474","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T15:10:17Z","timestamp":1660921817000},"page":"1857-1863","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":29,"title":["Phloretin Improves Ultrafiltration and Reduces Glucose Absorption during Peritoneal Dialysis in Rats"],"prefix":"10.1681","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2483-9495","authenticated-orcid":false,"given":"Karin","family":"Bergling","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Clinical Sciences Lund, Sk\u00e5ne University Hospital, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4273-5895","authenticated-orcid":false,"given":"Giedre","family":"Martus","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Clinical Sciences Lund, Sk\u00e5ne University Hospital, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2471-6914","authenticated-orcid":false,"given":"Carl M.","family":"\u00d6berg","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Clinical Sciences Lund, Sk\u00e5ne University Hospital, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10]]},"reference":[{"key":"B1-20250823","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.0894-0959.2004.17610.x","article-title":"Metabolic consequences of peritoneal dialysis","volume":"17","author":"Burkart","year":"2004","journal-title":"Semin Dial"},{"key":"B2-20250823","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/ndt\/gfz116","article-title":"New-onset glucose disorders in peritoneal dialysis patients: A meta-analysis and systematic review","volume":"35","author":"Xue","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"B3-20250823","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1681\/ASN.2021010080","article-title":"Acquired decline in ultrafiltration in peritoneal dialysis: The role of glucose","volume":"32","author":"Krediet","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B4-20250823","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1681\/ASN.V1251046","article-title":"Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis","volume":"12","author":"Davies","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"B5-20250823","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1046\/j.1523-1755.1998.00899.x","article-title":"Expression of glucose transporters in human peritoneal mesothelial cells","volume":"53","author":"Schr\u00f6ppel","year":"1998","journal-title":"Kidney Int"},{"key":"B6-20250823","first-page":"103","article-title":"Regulation of glucose transporters in human peritoneal mesothelial cells","volume":"16","author":"Fischereder","year":"2003","journal-title":"J Nephrol"},{"key":"B7-20250823","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lfs.2016.07.018","article-title":"Diabetes and exposure to peritoneal dialysis solutions alter tight junction proteins and glucose transporters of rat peritoneal mesothelial cells","volume":"161","author":"Debray-Garc\u00eda","year":"2016","journal-title":"Life Sci"},{"key":"B8-20250823","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000520894","article-title":"Peritoneal expression of sglt-2, glut1, and glut3 in peritoneal dialysis patients","volume":"47","author":"Schricker","year":"2022","journal-title":"Kidney Blood Press Res"},{"key":"B9-20250823","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/08968608211008095","article-title":"SGLT2 inhibition does not reduce glucose absorption during experimental peritoneal dialysis","volume":"41","author":"Martus","year":"2021","journal-title":"Perit Dial Int"},{"key":"B10-20250823","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.biopha.2018.10.106","article-title":"SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2","volume":"109","author":"Zhou","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"B11-20250823","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3390\/biom10111573","article-title":"Sglt2 inhibition by intraperitoneal dapagliflozin mitigates peritoneal fibrosis and ultrafiltration failure in a mouse model of chronic peritoneal exposure to high-glucose dialysate","volume":"10","author":"Balzer","year":"2020","journal-title":"Biomolecules"},{"key":"B12-20250823","article-title":"Dual SGLT1\/SGLT2 inhibitor phlorizin reduces glucose transport in experimental peritoneal dialysis","author":"Martus","journal-title":"Perit Dial Int"},{"key":"B13-20250823","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3390\/nu11051173","article-title":"Role of apple phytochemicals, phloretin and phloridzin, in modulating processes related to intestinal inflammation","volume":"11","author":"Zielinska","year":"2019","journal-title":"Nutrients"},{"key":"B14-20250823","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/molecules24020278","article-title":"Biochemical basis of anti-cancer-effects of phloretin-A natural dihydrochalcone","volume":"24","author":"Choi","year":"2019","journal-title":"Molecules"},{"key":"B15-20250823","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11101-017-9500-x","article-title":"Health effects of phloretin: From chemistry to medicine","volume":"16","author":"Behzad","year":"2017","journal-title":"Phytochem Rev"},{"key":"B16-20250823","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1055\/s-0043-106050","article-title":"Natural products as lead compounds for sodium glucose cotransporter (sglt) inhibitors","volume":"83","author":"Blaschek","year":"2017","journal-title":"Planta Med"},{"key":"B17-20250823","doi-asserted-by":"crossref","first-page":"C373","DOI":"10.1152\/ajpcell.00328.2011","article-title":"Structural selectivity of human SGLT inhibitors","volume":"302","author":"Hummel","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"B18-20250823","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000170209","article-title":"Intraperitoneal fluid volume changes during peritoneal dialysis in the rat: Indicator dilution vs. volumetric measurements","volume":"13","author":"Zakaria","year":"1995","journal-title":"Blood Purif"},{"key":"B19-20250823","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1172\/JCI106080","article-title":"Altered permeability of the peritoneal membrane after using hypertonic peritoneal dialysis fluid","volume":"48","author":"Henderson","year":"1969","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"B20-20250823","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1177\/089686089301302S09","article-title":"A three-pore model of peritoneal transport","volume":"13","author":"Rippe","year":"1993","journal-title":"Perit Dial Int"},{"key":"B21-20250823","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/0896860819895365","article-title":"Volume management as a key dimension of a high-quality PD prescription","volume":"40","author":"Wang","year":"2020","journal-title":"Perit Dial Int"},{"key":"B22-20250823","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/08968608211010055","article-title":"Optimization of bimodal automated peritoneal dialysis prescription using the three-pore model","volume":"41","author":"\u00d6berg","year":"2021","journal-title":"Perit Dial Int"},{"key":"B23-20250823","article-title":"Optimised versus standard automated peritoneal dialysis regimens pilot study (OptiStAR): A randomised controlled crossover trial","author":"Bergling","journal-title":"Perit Dial Int"},{"key":"B24-20250823","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/ckj\/sfaa035","article-title":"Characterization of sodium removal to ultrafiltration volume in a peritoneal dialysis outpatient cohort","volume":"14","author":"Jaques","year":"2020","journal-title":"Clin Kidney J"},{"key":"B25-20250823","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s40620-019-00646-7","article-title":"Comparison of sodium removal in peritoneal dialysis patients treated by continuous ambulatory and automated peritoneal dialysis","volume":"32","author":"Maharjan","year":"2019","journal-title":"J Nephrol"},{"key":"B26-20250823","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ki.2015.138","article-title":"Salt-sparing diuretic action of a water-soluble urea analog inhibitor of urea transporters UT-A and UT-B in rats","volume":"88","author":"Cil","year":"2015","journal-title":"Kidney Int"},{"key":"B27-20250823","author":"Bergling","year":"2022"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.2022040474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:49:05Z","timestamp":1786132145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.2022040474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2022040474","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"2022-04-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}